Use Biopath for risky short term speculation or day-trading. The stock experiences very speculative upward sentiment. The trend is possibly hyped up
1 Month Beta ..........
2.65
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Biopath will likely underperform.
Peter Nielsen Co-Founder, Chairman, CEO and President CFO, Chief Accounting Officer and Treasurer, MBA
Biopath Price and Market Media
The median price of Biopath for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 0.31 with a coefficient of variation of 8.53. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 0.32, and mean deviation of 0.02. The Stock did not receive any noticable media coverage during the period.
Biopath Holdings Inc [BPTH] is traded as part of a regulated electronic trading service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 20.02 M. Biopath Holdings Inc operates under Healthcare sector and is part of Drug Delivery industry. This company has 58.87 M outstanding shares.
Biopath Liquidity
The company has Current Ratio of 2.6 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
94% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
Management
Discussion
OTC BB
